Literature DB >> 15740013

Contribution of chlorogenic acids to the iron-reducing activity of coffee beverages.

Daniel P Moreira1, Mariana C Monteiro, Mirna Ribeiro-Alves, Carmen M Donangelo, Luiz C Trugo.   

Abstract

The iron-reducing activity of coffee beverages was determined by the ferric reducing antioxidant power (FRAP) assay. The influence on FRAP due to the degree of roasting (light, medium, and dark), species (Coffea arabica and Coffea robusta), and caffeine content (regular and decaffeinated) was investigated using ground and soluble coffee samples. The concentration of specific chlorogenic acids and caffeine in the beverages was determined by high-performance liquid chromatography and related to FRAP using Pearson correlation coefficients. All measurements were expressed per unit of soluble solids. Beverages prepared with ground coffee had, on average, 27% higher FRAP values than those prepared with soluble coffee (p < 0.05). In the former beverages, FRAP of C. robusta samples was significantly higher (on average, 50.3%) when compared to that of C. arabica samples, and FRAP values decreased with increasing degree of roasting (p < 0.05). A strong correlation (r > 0.91) was found between FRAP and the total content of chlorogenic acids, particularly that of the caffeoylquinic acid isomers. The iron-reducing activity of coffee beverages was not influenced by caffeine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15740013     DOI: 10.1021/jf0485436

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  5 in total

1.  Effect of the roasting levels of Coffea arabica L. extracts on their potential antioxidant capacity and antiproliferative activity in human prostate cancer cells.

Authors:  Laurent Dos Santos de Souza; Isabella Porto Carrero Horta; Lana de Souza Rosa; Larissa Gabrielly Barbosa Lima; Jeane Santos da Rosa; Julia Montenegro; Lauriza da Silva Santos; Raquel Bernardo Nana de Castro; Otniel Freitas-Silva; Anderson Junger Teodoro
Journal:  RSC Adv       Date:  2020-08-17       Impact factor: 4.036

2.  Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.

Authors:  Christina Bamia; Pagona Lagiou; Mazda Jenab; Antonia Trichopoulou; Veronika Fedirko; Krasimira Aleksandrova; Tobias Pischon; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Antoine Racine; Tilman Kuhn; Heiner Boeing; Anna Floegel; Vasiliki Benetou; Domenico Palli; Sara Grioni; Salvatore Panico; Rosario Tumino; Paolo Vineis; H B Bueno-de-Mesquita; Vincent K Dik; Nirmala Bhoo-Pathy; Cuno S P M Uiterwaal; Elisabete Weiderpass; Eiliv Lund; J Ramón Quirós; Raul Zamora-Ros; Esther Molina-Montes; Maria-Dolores Chirlaque; Eva Ardanaz; Miren Dorronsoro; Björn Lindkvist; Peter Wallström; Lena Maria Nilsson; Malin Sund; Kay-Tee Khaw; Nick Wareham; Kathryn E Bradbury; Ruth C Travis; Pietro Ferrari; Talita Duarte-Salles; Magdalena Stepien; Marc Gunter; Neil Murphy; Elio Riboli; Dimitrios Trichopoulos
Journal:  Int J Cancer       Date:  2014-09-24       Impact factor: 7.396

3.  Flaking process increases the NF-κB inhibition activity and melanoidin extractability of coffee.

Authors:  Yi-Fang Chu; Kang Hu; Thomas Hatzold; Richard M Black; Don Chen
Journal:  Food Sci Nutr       Date:  2012-12-26       Impact factor: 2.863

4.  The study of interactions between active compounds of coffee and willow (Salix sp.) bark water extract.

Authors:  Agata Durak; Urszula Gawlik-Dziki
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

5.  Phytochemical Composition, Antioxidant Activity, and the Effect of the Aqueous Extract of Coffee (Coffea arabica L.) Bean Residual Press Cake on the Skin Wound Healing.

Authors:  Regina Celis Lopes Affonso; Ana Paula Lorenzen Voytena; Simone Fanan; Heloísa Pitz; Daniela Sousa Coelho; Ana Luiza Horstmann; Aline Pereira; Virgílio Gavicho Uarrota; Maria Clara Hillmann; Lucas Andre Calbusch Varela; Rosa Maria Ribeiro-do-Valle; Marcelo Maraschin
Journal:  Oxid Med Cell Longev       Date:  2016-11-14       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.